nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Body temperature increased—Vinorelbine—ovarian cancer	0.000946	0.000946	CcSEcCtD
Tobramycin—Connective tissue disorder—Docetaxel—ovarian cancer	0.000943	0.000943	CcSEcCtD
Tobramycin—Urethral disorder—Docetaxel—ovarian cancer	0.000941	0.000941	CcSEcCtD
Tobramycin—Renal failure acute—Doxorubicin—ovarian cancer	0.000938	0.000938	CcSEcCtD
Tobramycin—Diarrhoea—Melphalan—ovarian cancer	0.000937	0.000937	CcSEcCtD
Tobramycin—Nausea—Chlorambucil—ovarian cancer	0.000933	0.000933	CcSEcCtD
Tobramycin—Vision blurred—Paclitaxel—ovarian cancer	0.000929	0.000929	CcSEcCtD
Tobramycin—Visual impairment—Docetaxel—ovarian cancer	0.000925	0.000925	CcSEcCtD
Tobramycin—Dizziness—Topotecan—ovarian cancer	0.000925	0.000925	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000918	0.000918	CcSEcCtD
Tobramycin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000915	0.000915	CcSEcCtD
Tobramycin—Anaemia—Paclitaxel—ovarian cancer	0.000911	0.000911	CcSEcCtD
Tobramycin—Renal impairment—Doxorubicin—ovarian cancer	0.00091	0.00091	CcSEcCtD
Tobramycin—Angioedema—Paclitaxel—ovarian cancer	0.000901	0.000901	CcSEcCtD
Tobramycin—Eye disorder—Docetaxel—ovarian cancer	0.000897	0.000897	CcSEcCtD
Tobramycin—Vomiting—Topotecan—ovarian cancer	0.000889	0.000889	CcSEcCtD
Tobramycin—Malaise—Paclitaxel—ovarian cancer	0.000889	0.000889	CcSEcCtD
Tobramycin—Vertigo—Paclitaxel—ovarian cancer	0.000886	0.000886	CcSEcCtD
Tobramycin—Lethargy—Doxorubicin—ovarian cancer	0.000884	0.000884	CcSEcCtD
Tobramycin—Leukopenia—Paclitaxel—ovarian cancer	0.000882	0.000882	CcSEcCtD
Tobramycin—Rash—Topotecan—ovarian cancer	0.000882	0.000882	CcSEcCtD
Tobramycin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000881	0.000881	CcSEcCtD
Tobramycin—Dermatitis—Topotecan—ovarian cancer	0.000881	0.000881	CcSEcCtD
Tobramycin—Blood creatinine increased—Epirubicin—ovarian cancer	0.000877	0.000877	CcSEcCtD
Tobramycin—Headache—Topotecan—ovarian cancer	0.000876	0.000876	CcSEcCtD
Tobramycin—Angiopathy—Docetaxel—ovarian cancer	0.000871	0.000871	CcSEcCtD
Tobramycin—Vomiting—Melphalan—ovarian cancer	0.000871	0.000871	CcSEcCtD
Tobramycin—Dehydration—Epirubicin—ovarian cancer	0.00087	0.00087	CcSEcCtD
Tobramycin—Immune system disorder—Docetaxel—ovarian cancer	0.000867	0.000867	CcSEcCtD
Tobramycin—Mediastinal disorder—Docetaxel—ovarian cancer	0.000865	0.000865	CcSEcCtD
Tobramycin—Rash—Melphalan—ovarian cancer	0.000863	0.000863	CcSEcCtD
Tobramycin—Dermatitis—Melphalan—ovarian cancer	0.000862	0.000862	CcSEcCtD
Tobramycin—Cough—Paclitaxel—ovarian cancer	0.00086	0.00086	CcSEcCtD
Tobramycin—Asthenia—Vinorelbine—ovarian cancer	0.000858	0.000858	CcSEcCtD
Tobramycin—Dry skin—Epirubicin—ovarian cancer	0.000858	0.000858	CcSEcCtD
Tobramycin—Hypokalaemia—Epirubicin—ovarian cancer	0.000852	0.000852	CcSEcCtD
Tobramycin—Pruritus—Vinorelbine—ovarian cancer	0.000846	0.000846	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000843	0.000843	CcSEcCtD
Tobramycin—Chest pain—Paclitaxel—ovarian cancer	0.000839	0.000839	CcSEcCtD
Tobramycin—Myalgia—Paclitaxel—ovarian cancer	0.000839	0.000839	CcSEcCtD
Tobramycin—Erythema—Docetaxel—ovarian cancer	0.000836	0.000836	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000834	0.000834	CcSEcCtD
Tobramycin—Nausea—Topotecan—ovarian cancer	0.000831	0.000831	CcSEcCtD
Tobramycin—Discomfort—Paclitaxel—ovarian cancer	0.000829	0.000829	CcSEcCtD
Tobramycin—Muscular weakness—Epirubicin—ovarian cancer	0.000825	0.000825	CcSEcCtD
Tobramycin—Diarrhoea—Vinorelbine—ovarian cancer	0.000818	0.000818	CcSEcCtD
Tobramycin—Dysgeusia—Docetaxel—ovarian cancer	0.000818	0.000818	CcSEcCtD
Tobramycin—Nausea—Melphalan—ovarian cancer	0.000813	0.000813	CcSEcCtD
Tobramycin—Confusional state—Paclitaxel—ovarian cancer	0.000811	0.000811	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000811	0.000811	CcSEcCtD
Tobramycin—Asthma—Epirubicin—ovarian cancer	0.000809	0.000809	CcSEcCtD
Tobramycin—Back pain—Docetaxel—ovarian cancer	0.000808	0.000808	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—ovarian cancer	0.000805	0.000805	CcSEcCtD
Tobramycin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000805	0.000805	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—ovarian cancer	0.000801	0.000801	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—ovarian cancer	0.000794	0.000794	CcSEcCtD
Tobramycin—Dizziness—Vinorelbine—ovarian cancer	0.000791	0.000791	CcSEcCtD
Tobramycin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000789	0.000789	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—ovarian cancer	0.000788	0.000788	CcSEcCtD
Tobramycin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000788	0.000788	CcSEcCtD
Tobramycin—Skin disorder—Paclitaxel—ovarian cancer	0.000782	0.000782	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00078	0.00078	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—ovarian cancer	0.000778	0.000778	CcSEcCtD
Tobramycin—Anaemia—Docetaxel—ovarian cancer	0.000772	0.000772	CcSEcCtD
Tobramycin—Anorexia—Paclitaxel—ovarian cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—ovarian cancer	0.000764	0.000764	CcSEcCtD
Tobramycin—Vomiting—Vinorelbine—ovarian cancer	0.000761	0.000761	CcSEcCtD
Tobramycin—Rash—Vinorelbine—ovarian cancer	0.000754	0.000754	CcSEcCtD
Tobramycin—Dermatitis—Vinorelbine—ovarian cancer	0.000754	0.000754	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000752	0.000752	CcSEcCtD
Tobramycin—Headache—Vinorelbine—ovarian cancer	0.000749	0.000749	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—ovarian cancer	0.000748	0.000748	CcSEcCtD
Tobramycin—Leukopenia—Docetaxel—ovarian cancer	0.000748	0.000748	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000733	0.000733	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—ovarian cancer	0.000732	0.000732	CcSEcCtD
Tobramycin—Cough—Docetaxel—ovarian cancer	0.000729	0.000729	CcSEcCtD
Tobramycin—Paraesthesia—Paclitaxel—ovarian cancer	0.000722	0.000722	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—ovarian cancer	0.000721	0.000721	CcSEcCtD
Tobramycin—Infestation—Epirubicin—ovarian cancer	0.000721	0.000721	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—ovarian cancer	0.00072	0.00072	CcSEcCtD
Tobramycin—Dyspnoea—Paclitaxel—ovarian cancer	0.000717	0.000717	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—ovarian cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—ovarian cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Nausea—Vinorelbine—ovarian cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—ovarian cancer	0.000709	0.000709	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000707	0.000707	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000706	0.000706	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—ovarian cancer	0.000703	0.000703	CcSEcCtD
Tobramycin—Decreased appetite—Paclitaxel—ovarian cancer	0.000699	0.000699	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000696	0.000696	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000695	0.000695	CcSEcCtD
Tobramycin—Pain—Paclitaxel—ovarian cancer	0.000688	0.000688	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—ovarian cancer	0.000688	0.000688	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000682	0.000682	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—ovarian cancer	0.00068	0.00068	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—ovarian cancer	0.000669	0.000669	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000668	0.000668	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—ovarian cancer	0.000667	0.000667	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—ovarian cancer	0.000667	0.000667	CcSEcCtD
Tobramycin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000663	0.000663	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—ovarian cancer	0.000662	0.000662	CcSEcCtD
Tobramycin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000658	0.000658	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—ovarian cancer	0.000656	0.000656	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000654	0.000654	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—ovarian cancer	0.00065	0.00065	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—ovarian cancer	0.00065	0.00065	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—ovarian cancer	0.000649	0.000649	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—ovarian cancer	0.000643	0.000643	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000639	0.000639	CcSEcCtD
Tobramycin—Urticaria—Paclitaxel—ovarian cancer	0.000639	0.000639	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Tobramycin—Abdominal pain—Paclitaxel—ovarian cancer	0.000636	0.000636	CcSEcCtD
Tobramycin—Body temperature increased—Paclitaxel—ovarian cancer	0.000636	0.000636	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—ovarian cancer	0.000635	0.000635	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—ovarian cancer	0.000629	0.000629	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—ovarian cancer	0.000626	0.000626	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—ovarian cancer	0.000624	0.000624	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000623	0.000623	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000621	0.000621	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—ovarian cancer	0.000612	0.000612	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—ovarian cancer	0.000608	0.000608	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—ovarian cancer	0.000605	0.000605	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—ovarian cancer	0.000601	0.000601	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—ovarian cancer	0.000595	0.000595	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—ovarian cancer	0.000593	0.000593	CcSEcCtD
Tobramycin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000593	0.000593	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000592	0.000592	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000589	0.000589	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000589	0.000589	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—ovarian cancer	0.000587	0.000587	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—ovarian cancer	0.000587	0.000587	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—ovarian cancer	0.000585	0.000585	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Tobramycin—Pain—Docetaxel—ovarian cancer	0.000583	0.000583	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—ovarian cancer	0.000577	0.000577	CcSEcCtD
Tobramycin—Asthenia—Paclitaxel—ovarian cancer	0.000577	0.000577	CcSEcCtD
Tobramycin—Pruritus—Paclitaxel—ovarian cancer	0.000569	0.000569	CcSEcCtD
Tobramycin—Erythema—Epirubicin—ovarian cancer	0.000564	0.000564	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—ovarian cancer	0.000562	0.000562	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—ovarian cancer	0.00056	0.00056	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000558	0.000558	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—ovarian cancer	0.000552	0.000552	CcSEcCtD
Tobramycin—Diarrhoea—Paclitaxel—ovarian cancer	0.00055	0.00055	CcSEcCtD
Tobramycin—Back pain—Epirubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—ovarian cancer	0.000544	0.000544	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—ovarian cancer	0.000541	0.000541	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00054	0.00054	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—ovarian cancer	0.000539	0.000539	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—ovarian cancer	0.000539	0.000539	CcSEcCtD
Tobramycin—Dizziness—Paclitaxel—ovarian cancer	0.000532	0.000532	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—ovarian cancer	0.000521	0.000521	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—ovarian cancer	0.000521	0.000521	CcSEcCtD
Tobramycin—Vomiting—Paclitaxel—ovarian cancer	0.000512	0.000512	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—ovarian cancer	0.000511	0.000511	CcSEcCtD
Tobramycin—Malaise—Epirubicin—ovarian cancer	0.000508	0.000508	CcSEcCtD
Tobramycin—Rash—Paclitaxel—ovarian cancer	0.000507	0.000507	CcSEcCtD
Tobramycin—Dermatitis—Paclitaxel—ovarian cancer	0.000507	0.000507	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—ovarian cancer	0.000506	0.000506	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Tobramycin—Headache—Paclitaxel—ovarian cancer	0.000504	0.000504	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—ovarian cancer	0.000502	0.000502	CcSEcCtD
Tobramycin—Cough—Epirubicin—ovarian cancer	0.000492	0.000492	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—ovarian cancer	0.000489	0.000489	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—ovarian cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—ovarian cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Tobramycin—Nausea—Paclitaxel—ovarian cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000477	0.000477	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—ovarian cancer	0.000474	0.000474	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—ovarian cancer	0.00047	0.00047	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—ovarian cancer	0.000469	0.000469	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—ovarian cancer	0.000467	0.000467	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—ovarian cancer	0.000467	0.000467	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—ovarian cancer	0.000464	0.000464	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—ovarian cancer	0.00046	0.00046	CcSEcCtD
Tobramycin—Cough—Doxorubicin—ovarian cancer	0.000455	0.000455	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—ovarian cancer	0.000451	0.000451	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—ovarian cancer	0.000451	0.000451	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00045	0.00045	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—ovarian cancer	0.000447	0.000447	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000441	0.000441	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—ovarian cancer	0.000439	0.000439	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—ovarian cancer	0.000438	0.000438	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—ovarian cancer	0.000434	0.000434	CcSEcCtD
Tobramycin—Rash—Docetaxel—ovarian cancer	0.00043	0.00043	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—ovarian cancer	0.00043	0.00043	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—ovarian cancer	0.000429	0.000429	CcSEcCtD
Tobramycin—Headache—Docetaxel—ovarian cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000419	0.000419	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000417	0.000417	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000417	0.000417	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—ovarian cancer	0.000406	0.000406	CcSEcCtD
Tobramycin—Nausea—Docetaxel—ovarian cancer	0.000405	0.000405	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—ovarian cancer	0.0004	0.0004	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Pain—Epirubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000388	0.000388	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—ovarian cancer	0.000382	0.000382	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000376	0.000376	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—ovarian cancer	0.00037	0.00037	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000367	0.000367	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—ovarian cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Pain—Doxorubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000351	0.000351	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000348	0.000348	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—ovarian cancer	0.000339	0.000339	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—ovarian cancer	0.000338	0.000338	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—ovarian cancer	0.000336	0.000336	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—ovarian cancer	0.000336	0.000336	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—ovarian cancer	0.00033	0.00033	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—ovarian cancer	0.000325	0.000325	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—ovarian cancer	0.000315	0.000315	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—ovarian cancer	0.000305	0.000305	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—ovarian cancer	0.000304	0.000304	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—ovarian cancer	0.000301	0.000301	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—ovarian cancer	0.000292	0.000292	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—ovarian cancer	0.000291	0.000291	CcSEcCtD
Tobramycin—Rash—Epirubicin—ovarian cancer	0.00029	0.00029	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—ovarian cancer	0.00029	0.00029	CcSEcCtD
Tobramycin—Headache—Epirubicin—ovarian cancer	0.000288	0.000288	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—ovarian cancer	0.000281	0.000281	CcSEcCtD
Tobramycin—Nausea—Epirubicin—ovarian cancer	0.000273	0.000273	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—ovarian cancer	0.000271	0.000271	CcSEcCtD
Tobramycin—Rash—Doxorubicin—ovarian cancer	0.000268	0.000268	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—ovarian cancer	0.000268	0.000268	CcSEcCtD
Tobramycin—Headache—Doxorubicin—ovarian cancer	0.000267	0.000267	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—ovarian cancer	0.000253	0.000253	CcSEcCtD
